ROYAL BANK OF CANADA - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,000
-90.0%
80
-92.9%
0.00%
Q3 2022$10,000
+100.0%
1,129
+41.1%
0.00%
Q2 2022$5,000
+25.0%
8000.0%0.00%
Q1 2022$4,0000.0%8000.0%0.00%
Q4 2021$4,000
-20.0%
8000.0%0.00%
Q3 2021$5,000
-79.2%
800
-78.2%
0.00%
Q2 2021$24,000
+20.0%
3,676
+37.7%
0.00%
Q1 2021$20,0000.0%2,670
-24.6%
0.00%
Q4 2020$20,000
+300.0%
3,543
+338.5%
0.00%
Q3 2020$5,000
+25.0%
808
+1.0%
0.00%
Q2 2020$4,000
+33.3%
8000.0%0.00%
Q1 2020$3,0008000.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,739,255$22,544,0007.01%
Worth Venture Partners, LLC 685,026$5,638,0003.45%
NEA Management Company, LLC 3,952,957$32,533,0001.62%
Birchview Capital, LP 140,000$1,152,0000.81%
Rubric Capital Management LP 1,664,667$13,700,0000.69%
EAM Investors, LLC 380,691$3,133,0000.68%
GLOBEFLEX CAPITAL L P 368,520$3,033,0000.52%
X-Square Capital, LLC 92,283$759,0000.48%
EAM Global Investors LLC 211,759$1,743,0000.46%
J. Goldman & Co LP 656,161$5,400,0000.26%
View complete list of AVEO PHARMACEUTICALS INC shareholders